Genomics of Islet (Dys)function and Type 2 Diabetes

Trends in Genetics

Volumn 33, Issue 4, 2017, Pages 244-255

  Lawlor, Nathan ^a   Khetan, Shubham ^a,b   Ucar, Duygu ^a,b   Stitzel, Michael L ^a,b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

epigenomics; genomics; pancreatic islets; single cell; transcriptomics; Type 2 diabetes (T2D)

Indexed keywords

TRANSCRIPTOME;

AGING; CELL HETEROGENEITY; CIRCADIAN RHYTHM; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL CHANGE; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; INFLAMMATION; LIFESTYLE; MOLECULAR GENETICS; NEXT GENERATION SEQUENCING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; PANCREAS ISLET DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTOMICS; WESTERN DIET; GENE EDITING; GENETICS; HUMAN GENOME; METABOLISM; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOLOGY; SINGLE CELL ANALYSIS;

DIABETES MELLITUS, TYPE 2; GENE EDITING; GENOME, HUMAN; GENOMICS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; SINGLE-CELL ANALYSIS; TRANSCRIPTOME;

EID: 85013785118     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2017.01.010     Document Type: Review

References (101)

1. 1 Mohlke, K.L., Boehnke, M., Recent advances in understanding the genetic architecture of type 2 diabetes. Hum. Mol. Genet. 24 (2015), R85–R92.
2. 2 Parker, S.C.J., et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 17921–17926.
3. 3 Pasquali, L., et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 46 (2014), 136–143.
4. 4 Roadmap Epigenomics Consortium, et al. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
5. 5 Quang, D.X., et al. Motif signatures in stretch enhancers are enriched for disease-associated genetic variants. Epigenetics Chromatin, 8, 2015, 23.
6. 6 Trynka, G., et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45 (2013), 124–130.
7. 7 Finucane, H.K., et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47 (2015), 1228–1235.
8. 8 Stitzel, M.L., et al. Transcriptional regulation of the pancreatic islet: implications for islet function. Curr. Diab. Rep., 15, 2015, 66.
9. 9 Kulzer, J.R., et al. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am. J. Hum. Genet. 94 (2014), 186–197.
10. 10 Fogarty, M.P., et al. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLOS Genet., 10, 2014, e1004633.
11. 11 van de Bunt, M., et al. Transcript expression data from human islets links regulatory signals from genome-wide association studies for type 2 diabetes and glycemic traits to their downstream effectors. PLoS Genet., 11, 2015, e1005694.
12. 12 DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46 (2014), 234–244.
13. 13 Morris, A.P., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44 (2012), 981–990.
14. 14 Fuchsberger, C., et al. The genetic architecture of type 2 diabetes. Nature 536 (2016), 41–47.
15. 15 Gaulton, K.J., et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47 (2015), 1415–1425.
16. 16 Agarwala, V., et al. Evaluating empirical bounds on complex disease genetic architecture. Nat. Genet. 45 (2013), 1418–1427.
17. 17 Strawbridge, R.J., Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60 (2011), 2624–2634.
18. 18 Steinthorsdottir, V., Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 46 (2014), 294–298.
19. 19 Hara, K., et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum. Mol. Genet. 23 (2014), 239–246.
20. 20 Aouacheri, O., et al. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can. J. Diabetes 39 (2015), 44–49.
21. 21 Chaudhari, N., et al. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front. Cell. Neurosci., 8, 2014, 213.
22. 22 Gorasia, D.G., et al. Pancreatic beta cells are highly susceptible to oxidative and ER stresses during the development of diabetes. J. Proteome Res. 14 (2015), 688–699.
23. 23 Rando, O.J., Simmons, R.A., I'm eating for two: parental dietary effects on offspring metabolism. Cell 161 (2015), 93–105.
24. 24 Zephy, D., Ahmad, J., Type 2 diabetes mellitus: role of melatonin and oxidative stress. Diabetes Metab. Syndr. Clin. Res. Rev. 9 (2015), 127–131.
25. 25 Laybutt, D.R., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50 (2007), 752–763.
26. 26 Scott, L.J., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007), 1341–1345.
27. 27 Sladek, R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007), 881–885.
28. 28 Burton, P.R., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007), 661–678.
29. 29 Diabetes Genetics Initiative of the Broad Institute of Harvard, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007), 1331–1336.
30. 30 Liu, C.-T., et al. Trans-ethnic meta-analysis and functional annotation illuminates the genetic architecture of fasting glucose and insulin. Am. J. Hum. Genet. 99 (2016), 56–75.
31. 31 Fadista, J., et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 13924–13929.
32. 32 Stitzel, M.L., et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab. 12 (2010), 443–455.
33. 33 Ackermann, A.M., et al. Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol. Metab. 5 (2016), 233–244.
34. 34 Hnisz, D., et al. Super-enhancers in the control of cell identity and disease. Cell 155 (2013), 934–947.
35. 35 Dekker, J., Mirny, L., The 3D genome as moderator of chromosomal communication. Cell 164 (2016), 1110–1121.
36. 36 Lieberman-Aiden, E., Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326 (2009), 289–293.
37. 37 Li, G., et al. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biol., 11, 2010, R22.
38. 38 Mumbach, M.R., et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat. Methods 13 (2016), 919–922.
39. 39 Keller, M.P., et al. The transcription factor Nfatc2 regulates β-cell proliferation and genes associated with type 2 diabetes in mouse and human islets. PLOS Genet., 12, 2016, e1006466.
40. 40 Scott, L.J., et al. The genetic regulatory signature of type 2 diabetes in human skeletal muscle. Nat. Commun., 7, 2016, 11764.
41. 41 Small, K.S., et al. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 43 (2011), 561–564.
42. 42 Morán, I., et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 16 (2012), 435–448.
43. 43 Arnes, L., Sussel, L., Epigenetic modifications and long noncoding RNAs influence pancreas development and function. Trends Genet. 31 (2015), 290–299.
44. 44 Voight, B.F., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42 (2010), 579–589.
45. 45 Wallace, C., et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 42 (2010), 68–71.
46. 46 Dayeh, T., et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet., 10, 2014, e1004160.
47. 47 Volkmar, M., et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 31 (2012), 1405–1426.
48. 48 Arda, H.E., et al. Age-dependent pancreatic gene regulation reveals mechanisms governing human β cell function. Cell Metab. 23 (2016), 909–920.
49. 49 Avrahami, D., et al. Aging-dependent demethylation of regulatory elements correlates with chromatin state and improved β cell function. Cell Metab. 22 (2015), 619–632.
50. 50 Perelis, M., et al. Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Science, 350, 2015, aac4250.
51. 51 Kluth, O., et al. Differential transcriptome analysis of diabetes-resistant and -sensitive mouse islets reveals significant overlap with human diabetes susceptibility genes. Diabetes 63 (2014), 4230–4238.
52. 52 Persaud, S.J., Jones, P.M., A wake-up call for type 2 diabetes?. N. Engl. J. Med. 375 (2016), 1090–1092.
53. 53 Halban, P.A., et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37 (2014), 1751–1758.
54. 54 Schulz, L.C., The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. 107 (2010), 16757–16758.
55. 55 Li, J., et al. Prenatal exposure to famine and the development of hyperglycemia and type 2 diabetes in adulthood across consecutive generations: a population-based cohort study of families in Suihua, China. Am. J. Clin. Nutr. 105 (2017), 221–227.
56. 56 Rakyan, V.K., et al. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12 (2011), 529–541.
57. 57 Dai, C., et al. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. J. Clin. Invest. 126 (2016), 1857–1870.
58. 58 Dai, C., et al. Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets. Diabetologia 55 (2012), 707–718.
59. 59 Guo, S., et al. Inactivation of specific β cell transcription factors in type 2 diabetes. J. Clin. Invest. 123 (2013), 3305–3316.
60. 60 Lee, M.N., et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science, 343, 2014, 1246980.
61. 61 Blodgett, D.M., et al. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes 64 (2015), 3172–3181.
62. 62 Brissova, M., et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 53 (2005), 1087–1097.
63. 63 Cabrera, O., et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 2334–2339.
64. 64 Ionescu-Tirgoviste, C., A 3D map of the islet routes throughout the healthy human pancreas. Sci. Rep., 5, 2015, 14634.
65. 65 Stanojevic, V., Habener, J.F., Evolving function and potential of pancreatic alpha cells. Best Pract. Res. Clin. Endocrinol. Metab. 29 (2015), 859–871.
66. 66 Jamison, R.A., et al. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E1174–E1183.
67. 67 Rodriguez-Diaz, R., Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat. Med. 17 (2011), 888–892.
68. 68 Hauge-Evans, A.C., Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58 (2009), 403–411.
69. 69 van der Meulen, T., Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat. Med. 21 (2015), 769–776.
70. 70 DiGruccio, M.R., et al. Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. Mol. Metab. 5 (2016), 449–458.
71. 71 Molina, J., et al. Control of insulin secretion by cholinergic signaling in the human pancreatic islet. Diabetes 63 (2014), 2714–2726.
72. 72 Bramswig, N.C., et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J. Clin. Invest. 123 (2013), 1275–1284.
73. 73 Dorrell, C., et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 54 (2011), 2832–2844.
74. 74 Nica, A.C., et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res. 23 (2013), 1554–1562.
75. 75 Lawlor, N., et al. Single cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res. 27 (2017), 208–222.
76. 76 Baron, M., et al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst. 3 (2016), 346–360.
77. 77 Grün, D., et al. De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell 19 (2016), 266–277.
78. 78 Li, J., et al. Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types. EMBO Rep. 17 (2016), 178–187.
79. 79 Muraro, M.J., et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3 (2016), 385–394.
80. 80 Segerstolpe, Å., et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 24 (2016), 593–607.
81. 81 Wang, Y.J., et al. Single cell transcriptomics of the human endocrine pancreas. Diabetes 65 (2016), 3028–3038.
82. 82 Xin, Y., et al. Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 3293–3298.
83. 83 Xin, Y., et al. RNA sequencing of single human islet cells reveals type 2 diabetes genes. Cell Metab. 24 (2016), 608–615.
84. 84 Dorrell, C., et al. Human islets contain four distinct subtypes of β cells. Nat. Commun., 7, 2016, 11756.
85. 85 Bader, E., et al. Identification of proliferative and mature β-cells in the islets of Langerhans. Nature 535 (2016), 430–434.
86. 86 Wang, Y.J., et al. Single-cell mass cytometry analysis of the human endocrine pancreas. Cell Metab. 24 (2016), 616–626.
87. 87 Liu, S., Trapnell, C., Single-cell transcriptome sequencing: recent advances and remaining challenges. F1000Research, 5, 2016, 182.
88. 88 Cinti, F., et al. Evidence of β-cell dedifferentiation in human type 2 diabetes. J. Clin. Endocrinol. Metab. 101 (2016), 1044–1054.
89. 89 Lu, J., et al. Transdifferentiation of pancreatic α-cells into insulin-secreting cells: from experimental models to underlying mechanisms. World J. Diabetes 5 (2014), 847–853.
90. 90 Talchai, C., et al. Pancreatic β-cell dedifferentiation as mechanism of diabetic β-cell failure. Cell 150 (2012), 1223–1234.
91. 91 Wang, Z., et al. Pancreatic β-cell dedifferentiation in diabetes and re-differentiation following insulin therapy. Cell Metab. 19 (2014), 872–882.
92. 92 Butler, A.E., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003), 102–110.
93. 93 Butler, A.E., et al. β-cell deficit in obese type 2 diabetes, a minor role of β-cell dedifferentiation and degranulation. J. Clin. Endocrinol. Metab. 101 (2016), 523–532.
94. 94 Sheedy, F.J., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation. Nat. Immunol. 14 (2013), 812–820.
95. 95 Kumasaka, N., et al. Fine-mapping cellular QTLs with RASQUAL and ATAC-seq. Nat. Genet. 48 (2016), 206–213.
96. 96 Degner, J.F., et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482 (2012), 390–394.
97. 97 Thomsen, S.K., et al. Systematic functional characterization of candidate causal genes for type 2 diabetes risk variants. Diabetes 65 (2016), 3805–3811.
98. 98 Soleimanpour, S.A., Stoffers, D.A., The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?. Trends Endocrinol. Metab. 24 (2013), 324–331.
99. 99 Maller, J.B., et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44 (2012), 1294–1301.
100. 100 Cerf, M.E., Beta cell dysfunction and insulin resistance. Front. Endocrinol., 4, 2013, 37.
101. 101 Halban, P.A., et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37 (2014), 1751–1758.